685
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease

, , , , , , , & show all
Pages 227-234 | Received 19 Jan 2015, Accepted 20 May 2014, Published online: 22 May 2015

References

  • de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525–35.
  • Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157(11):1015–22.
  • Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006;5(4):355–63.
  • Marder KS, Tang MX, Mejia-Santana H, et al. Predictors of parkin mutations in early-onset Parkinson's disease: the consortium on risk for early-onset Parkinson's disease study. Arch Neurol 2010;67(6):731–38.
  • Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000;342(21):1560–67.
  • Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40(10):1529–34.
  • Dubois B, Pillon B, Sternic N, et al. Age-induced cognitive disturbances in Parkinson's disease. Neurology 1990;40(1):38–41.
  • Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord 2014;20(1):99–105.
  • Alcalay RN, Caccappolo E, Mejia-Santana H, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology 2012;78(18):1434–40.
  • Papapetropoulos S, Argyriou AA, Ellul J. Clinical characteristics of late-onset Parkinson's disease. Arch Neurol 2003;60(12):1815–16.
  • Marras C, Armstrong MJ, Meaney CA, et al. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord 2013;28(5):626–33.
  • Fjell AM, Walhovd KB. P300 and neuropsychological tests as measures of aging: scalp topography and cognitive changes. Brain Topogr 2001;14(1):25–40.
  • Parra MA, Ascencio LL, Urquina HF, et al. P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer's dementia. Front Neurol 2012;3:172.
  • Papaliagkas VT, Kimiskidis VK, Tsolaki MN, et al. Cognitive event-related potentials: longitudinal changes in mild cognitive impairment. Clin Neurophysiol 2011;122(7):1322–26.
  • van Deursen JA, Vuurman EF, Smits LL, et al. Response speed, contingent negative variation and P300 in Alzheimer's disease and MCI. Brain Cogn 2009;69(3):592–99.
  • Bonanni L, Franciotti R, Onofrj V, et al. Revisiting P300 cognitive studies for dementia diagnosis: early dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Neurophysiol Clin 2010;40(5–6):255–65.
  • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181–84.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–98.
  • Gong Y-X G. Wechsler adult intelligence scale (WAIS-RC), Chinese version. Changsha, Hunan, China: Hunan Maping Press; 1992.
  • Gong Y-X. Wechsler memory scale, Chinese revision. Changsha, Hunan, China: Hunan Maping Press; 1992.
  • Leentjens AF, Dujardin K, Marsh L, et al. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 2011;26(3):407–15.
  • Hozumi A, Hirata K, Tanaka H, Yamazaki K. Perseveration for novel stimuli in Parkinson's disease: an evaluation based on event-related potentials topography. Mov Disord 2000;15(5):835–42.
  • Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson's disease. Neurology 2010;75(19):1717–25.
  • Katsarou Z, Bostantjopoulou S, Kimiskidis V, et al. Auditory event-related potentials in Parkinson's disease in relation to cognitive ability. Percept Mot Skills 2004;98(3, Pt 2):1441–48.
  • Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 2003;54(4):507–13.
  • Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003;126(Pt 6):1271–78.
  • van der Merwe C, Haylett W, Harvey J, et al. Factors influencing the development of early- or late-onset Parkinson's disease in a cohort of South African patients. S Afr Med J 2012;102(11, Pt 1):848–51.
  • Barone P, Aarsland D, Burn D, et al. Cognitive impairment in nondemented Parkinson's disease. Mov Disord 2011;26(14):2483–95.
  • Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited – clinical features, natural history, and mortality. Mov Disord 1998;13(6):885–94.
  • Lee CS, Schulzer M, Mak EK. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994;117(Pt 3):501–07.
  • Wickremaratchi MM, Ben-Shlomo Y, Morris HR. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol 2009;16(4):450–56.
  • Diamond SG, Markham CH, Hoehn MM, et al. Effect of age at onset on progression and mortality in Parkinson's disease. Neurology 1989;39(9):1187–90.
  • Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited – clinical features, natural history, and mortality. Mov Disord 1988;13(6):885–94.
  • Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54(8):1596–1602.
  • Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 2004;19(9):1043–49.
  • Levy G. The relationship of Parkinson's disease with aging. Arch Neurol 2007;64(9):1242–46.
  • Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology 2005;65(8):1239–45.
  • Lewis SJ, Dove A, Robbins TW, et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23(15):6351–56.
  • Zadikoff C, Fox SH, Tang-Wai DF, et al. A comparison of the Mini Mental State Exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008;23(2):297–99.
  • Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–99.
  • Hu MT, Szewczyk-Krolikowski K, Tomlinson P, et al. Predictors of cognitive impairment in an early-stage Parkinson's disease cohort. Mov Disord 2014;29(3):351–59.
  • Yu J, Li J, Huang X. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry 2012;25(12):156.
  • Siepel FJ, Bronnick KS, Booij J, et al. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease. Mov Disord 2014;29(14):1802–8.
  • Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9(12):1200–13.
  • Aarsland D, Kvaloy JT, Andersen K, et al. The effect of age of onset of PD on risk of dementia. J Neurol 2007;254(1):38–45.
  • Duarte JL, Alvarenga Kde F, Banhara MR, et al. P300-long-latency auditory evoked potential in normal hearing subjects: simultaneous recording value in Fz and Cz. Braz J Otorhinolaryngol 2009;75(2):231–36.
  • Nojszewska M, Pilczuk B, Zakrzewska-Pniewska B, Rowinska-Marcinska K. The auditory system involvement in Parkinson's disease: electrophysiological and neuropsychological correlations. J Clin Neurophysiol 2009;26(6):430–37.
  • Ebmeier KP. A quantitative method for the assessment of overall effects from a number of similar electrophysiological studies: description and application to event-related potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1992;84(5):440–46.
  • Pang S, Borod JC, Hernandez A, et al. The auditory P300 correlates with specific cognitive deficits in Parkinson's disease. J Neural Transm 1990;2(4):249–64.
  • Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002;53(2):647–54.
  • Chen KJ, Lin RT, Liu CK, et al. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2006;12(7):453–58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.